Finally, although not specifically investigated in this study, we should mention that BPC 157 therapy, in addition to decreasing increased serum amylase, counteracted the increased ALT, AST, bilirubin, urea, and creatinine values
Nerve Regeneration A crucial role of B12 is rejuvenating impaired nerves
This prescription form of B12 is the one most often recommended by healthcare professionals, including primary healthcare services, because it stays in the body for longer, only requiring repeat injection every three months
In fact, among mice that underwent exercise training, the majority of the proteins with changed levels from adding 5-amino-1MQ treatment did not coincide with those that went untreated
The complete side effect frequency breakdown from Phase 2 trials: Very Common (20%+ of patients at 12mg dose) Nausea: 28% Typically mild to moderate, peaks weeks 4-8, usually resolves by week 12 Diarrhea: 24% Usually transient (1-3 weeks), rarely severe Constipation: 21% Paradoxically coexists with diarrhea in different patients Common (10-20% of patients) Vomiting: 17% Decreased appetite: 16% (beyond therapeutic effect) Injection site reactions: 14% Fatigue: 13% Dyspepsia (indigestion): 12% Headache: 11% Uncommon (2-10% of patients) Abdominal pain: 8% Dizziness: 7% Gastroesophageal reflux: 6% Hypoglycemia in diabetics on other medications: 5% Increased heart rate (average 2-4 bpm): 4% Hair thinning/loss: 3% (typically temporary) Rare but Serious (Under 2%) Pancreatitis: 0.3% (3 cases out of 1,032 patients, all resolved with discontinuation) Gallbladder events: 1.4% (expected with rapid weight loss regardless of method) Acute kidney injury: 0.7% (all cases associated with severe dehydration) KEY TAKEAWAY: About 30% experience meaningful nausea in the first 4-8 weeks
